PerspectiveDiabetic Macular Edema: What Is Focal and What Is Diffuse?
Section snippets
Clinical Examination
SUPPLEMENTAL TABLE 1, SUPPLEMENTAL TABLE 2, SUPPLEMENTAL TABLE 3, SUPPLEMENTAL TABLE 4, SUPPLEMENTAL TABLE 5, SUPPLEMENTAL TABLE 6, SUPPLEMENTAL TABLE 7 (available at AJO.com) summarize the frequency with which various definitions have been used for the different methods. The ETDRS defined clinically significant DME as edema satisfying any one of the following three criteria: 1) any retinal thickening within 500 μm of the center of the macula, 2) hard exudates within 500 μm of the center of the
Color Fundus Photographs
Definitions involving color fundus photographs often involve area criteria. Larssen and associates state that “[d]iffuse macular edema was defined as having two or more disc areas of retinal thickening and involving the center of the macula” and that “[f]ocal edema was defined as an area of retinal thickening less than 2 disc areas in diameter not affecting the center of the macula.”50 The cutpoint for area and the necessity of involvement of the macular center for defining diffuse edema have
Fluorescein Angiography
In the ETDRS, DME was defined clinically from stereoscopic biomicroscopy without reference to focal or diffuse descriptions of that clinical examination. As stated in ETDRS Report No. 5, “Fluorescein leakage without retinal thickening was not included as part of the definition of macular edema in the ETDRS.”51 However, FAs were analyzed by a reading center and the source of fluorescein leakage was graded categorically by proportion of leakage originating from microaneurysms for classification
Optical Coherence Tomography
The use of OCT to define edema as focal or diffuse has been developed from two differing perspectives—that of the regional map and that of cross-sectional scans. In the false color map, a sense of focality can be obtained when isolated islands of hot colors are surrounded by larger areas of cool colors, but this is difficult to quantitate. Browning and Fraser suggested that diffuse DME be understood to imply an increasing number of elevated subfields on the map display.65 Sadda and associates
Hybrid Definitions
Hybrid definitions have been used frequently to define diffuse DME, but not focal DME. The definitions can be categorized into a subgroup using clinical examination and FA criteria and a subgroup using clinical examination, FA, and OCT criteria. The differences in criteria between the studies are summarized in SUPPLEMENTAL TABLE 1, SUPPLEMENTAL TABLE 2 available at AJO.com, along with undefined terms. Broadly speaking, the definitions differ in how much of the macula must be thickened or
Potential Problems With Different Definitions
Lobo and associates simultaneously obtained color fundus photographs, images with the Retinal Leakage Analyzer (Talia Technology, Lod, Israel) and thickness measurements with the Retinal Thickness Analyzer (Talia Technology) in diabetic eyes without and with retinopathy.77, 78 They found that the areas of retinal leakage frequently did not coincide with the areas of increased retinal thickness. They also found, counterintuitively, that microaneurysms showed relatively little leakage and over
Claims About Diffuse and Focal Diabetic Macular Edema
Many authors have claimed that diffuse DME is refractory to macular photocoagulation and that diffuse DME is a prognostic factor for poorer VA at follow-up, but the evidence for these claims comes from case series and not prospective clinical trials in which strict definitions were applied.2, 16, 24, 57, 79, 80 Others have suggested that diffuse DME responds better to intravitreal triamcinolone injection and focal DME to focal laser photocoagulation.43, 62, 81 The evidence to support the claims
A Fresh Look at the Definitions
Within the DRCR.net, a working group has been attempting to clarify the terms focal DME and diffuse DME. Its purpose is to determine if definitions can be developed that are clinically applicable and reproducible. Because of a variety of associations attached to the terms focal DME and diffuse DME, it may be more constructive to recast the discussion with newer terms describing discrete parts of the concepts such as extent and location of thickening, involvement or not of the center of the
References (86)
- et al.
Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema
Ophthalmology
(2005) - et al.
Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up
Ophthalmology
(2007) Diabetic macular edemaA review
Ophthalmology
(1986)- et al.
Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema
Am J Ophthalmol
(2005) - et al.
The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema
Am J Ophthalmol
(2004) - et al.
Comparison of intravitreal versus posterior sub-tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema
Ophthalmology
(2005) - et al.
Tomographic findings of foveal hard exudates in diabetic macular edema
Am J Ophthalmol
(2001) - et al.
Tomographic assessment of vitreous surgery for diabetic macular edema
Am J Ophthalmol
(2000) - et al.
Bevacizumab and retinal ischemia
Ophthalmology
(2007) - et al.
Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy
Am J Ophthalmol
(2003)
Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation
Am J Ophthalmol
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales
Ophthalmology
Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema
Am J Ophthalmol
Modified grid laser photocoagulation for diffuse diabetic macular edemaLong-term visual results
Ophthalmology
Intravitreal triamcinolone for refractory diabetic macular edema
Ophthalmology
The importance of fluorescein angiography in planning laser treatment of diabetic macular edema
Ophthalmology
Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography
Ophthalmology
Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial
Ophthalmology
Diabetic maculopathyA critical review highlighting diffuse macular edema
Ophthalmology
Relation of diabetic macular edema to cytokines and posterior vitreous detachment
Am J Ophthalmol
The effect if intravitreal triamcinolone on diabetic macular oedema
Graefes Arch Clin Exp Ophthalmol
Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation
Eye
Intravitreal triamcinolone for the treatment of refractory diabetic macular edema with hard exudates: an optical coherence tomography study
Br J Ophthalmol
Retrobulbar injection of methylprednisolone in diffuse diabetic macular edema
Retina
Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates
Graefes Arch Clin Exp Ophthalmol
Intravitreal injection of triamcinolone for diffuse diabetic macular edema
Arch Ophthalmol
Grid photocoagulation for diffuse macular edema
Retina
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
Retina
The National Diabetic Retinopathy Laser Treatment Audit. IMaculopathy
Eye
Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema
Graefes Arch Clin Exp Ophthalmol
Laser photocoagulation control of diabetic macular oedema without fluorescein angiography
Br J Ophthalmol
Progressive changes in diabetics and their management
Eye
Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema
Retina
Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin
Retina
Diabetic macular edema: a critical review of the early treatment diabetic retinopathy study (ETDRS) series and subsequent studies
Compr Ophthalmol Update
Retinal function in diabetic macular edema after focal laser photocoagulation
Invest Ophthalmol Vis Sci
The nature and extent of retinal dysfunction associated with diabetic macular edema
Invest Ophthalmol Vis Sci
Focal photocoagulation treatment of diabetic macular edemaRelationship of treatment effects to fluorescein angiographic and other retinal characteristics at baseline: ETDRS Report No. 19
Arch Ophthalmol
Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema
Arch Ophthalmol
Diabetic macular edema and argon laser photocoagulation: a prospective randomized study
Ophthalmology
Contrast sensitivity following focal laser photocoagulation in clinically significant macular oedema due to diabetic retinopathy
Clin and Experiment Ophthalmol
Photocoagulation of diabetic macular oedema—complications and visual outcome
Acta Ophthalmol Scand
Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial
Invest Ophthalmol Vis Sci
Cited by (115)
Optical coherence tomography in the management of diabetic macular oedema
2024, Progress in Retinal and Eye ResearchThe Clinical Signal-to-Noise Ratio of OCT Angiography: Key Applications for Routine Clinical Use
2022, Ophthalmology RetinaMultimodal Imaging-Based Central Serous Chorioretinopathy Classification
2020, Ophthalmology RetinaValidation of Esaso Classification of Diabetic Maculopathy
2024, European Journal of OphthalmologyFlare levels after intravitreal injection of brolucizumab for diabetic macular edema
2024, Graefe's Archive for Clinical and Experimental Ophthalmology
Supplemental Material available at AJO.com.